Literature DB >> 449690

Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids.

M Cigolini, U Smith.   

Abstract

Biopsies of human adipose tissue were maintained for 1 wk in vitro with physiologic (1.5-30 X 10(-8) M) or pharmacologic (300 X 10(-8) M) concentrations of hydrocortisone or 1000 muU/ml insulin, or both. After this period, the explants were washed and incubated for 2 hr according to techniques generally used to study fat cell metabolism. Physiologic concentrations of hydrocortisone mainly exert an insulin antagonistic effect. Thus, the long-term effects of insulin in increasing lipolysis, as well as glucose metabolism to triglycerides, were reduced, as were the acute effects of insulin on these parameters. At these concentrations, the glucocorticoid itself did not influence the basal metabolic rates when due consideration was given to simultaneous changes in mean fat cell size. At higher concentrations, which may easily be reached during nonspecific glucocorticoid therapy, the glucose metabolism was reduced. Hydrocortisone decreased the number of insulin receptors. However, this cannot solely explain the insulin-antagonistic effect, since it was not overcome by a supramaximal concentration of insulin. Insulin and hydrocortisone together increased the lipoprotein lipase (lpl) activity several times. The resultant changes in LPL appear to depend upon the insulincorticosteroid ratio.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 449690     DOI: 10.1016/0026-0495(79)90189-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

Review 1.  Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?

Authors:  P G Kopelman
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 2.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study.

Authors:  Mi-Jeong Lee; Da-Wei Gong; Bryan F Burkey; Susan K Fried
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

4.  Culture of isolated human adipocytes and isolated adipose tissue.

Authors:  Kirstin A Carswell; Mi-Jeong Lee; Susan K Fried
Journal:  Methods Mol Biol       Date:  2012

5.  Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue.

Authors:  James P Warne; Christopher D John; Helen C Christian; John F Morris; Roderick J Flower; David Sugden; Egle Solito; Glenda E Gillies; Julia C Buckingham
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07-11       Impact factor: 4.310

6.  Interactions of insulin and dexamethasone in the control of pyruvate kinase activity and glucose metabolism in sheep adipose tissue.

Authors:  C P Plested; E Taylor; D N Brindley; R G Vernon
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

7.  Control of insulin receptor level in 3T3 cells: effect of insulin-induced down-regulation and dexamethasone-induced up-regulation on rate of receptor inactivation.

Authors:  V P Knutson; G V Ronnett; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Metabolic effects of nicotine on human adipose tissue in organ culture.

Authors:  T Chajek-Shaul; G Scherer; V Barash; E Shiloni; Y Caine; O Stein; Y Stein
Journal:  Clin Investig       Date:  1994-01

9.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

10.  Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.

Authors:  M K Sinha; L G Taylor; W J Pories; E G Flickinger; D Meelheim; S Atkinson; N S Sehgal; J F Caro
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.